Navigation Links
Flightless mosquitoes developed to help control dengue fever
Date:2/22/2010

Irvine, Calif. A new strain of mosquitoes in which females cannot fly may help curb the transmission of dengue fever, according to UC Irvine and British scientists.

Dengue fever causes severe flulike symptoms and is among the world's most pressing public health issues. There are 50 million to 100 million cases per year, and nearly 40 percent of the global population is at risk. The dengue virus is spread through the bite of infected female Aedes aegypti mosquitoes, and there is no vaccine or treatment.

UCI researchers and colleagues from Oxitec Ltd. and the University of Oxford created the new breed. Flightless females are expected to die quickly in the wild, curtailing the number of mosquitoes and reducing or even eliminating dengue transmission. Males of the strain can fly but do not bite or convey disease.

When genetically altered male mosquitoes mate with wild females and pass on their genes, females of the next generation are unable to fly. Scientists estimate that if released, the new breed could sustainably suppress the native mosquito population in six to nine months. The approach offers a safe, efficient alternative to harmful insecticides.

Study results appear in the early online edition of the Proceedings of the National Academy of Sciences for the week of Feb. 22. The research is receiving funding support from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative, which was launched to support breakthrough advances for health challenges in the developing world.

"Current dengue control methods are not sufficiently effective, and new ones are urgently needed," said Anthony James, Distinguished Professor of microbiology & molecular genetics and molecular biology & biochemistry at UCI and an internationally recognized vector biologist. "Controlling the mosquito that transmits this virus could significantly reduce human morbidity and mortality."

Using concepts developed by Oxitec's Luke Alphey, the study's senior author, researchers made a genetic alteration in the mosquitoes that disrupts wing muscle development in female offspring, rendering them incapable of flight. Males' ability to fly is unaffected, and they show no ill effects from carrying the gene.

"The technology is completely species-specific, as the released males will mate only with females of the same species," Alphey said. "It's far more targeted and environmentally friendly than approaches dependent upon the use of chemical spray insecticides, which leave toxic residue."

"Another attractive feature of this method is that it's egalitarian: All people in the treated areas are equally protected, regardless of their wealth, power or education," he added.

James and Alphey have pioneered the creation of genetically altered mosquitoes to limit transmission of vector-borne illnesses. While their current work is focused on the dengue fever vector, they noted that this approach could be adapted to other mosquito species that spread such diseases as malaria and West Nile fever.


'/>"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine
Source:Eurekalert

Related medicine news :

1. Smaller mosquitoes are more likey to be infected with viruses causing human diseases
2. Vaccine and drug research aimed at ticks and mosquitoes to prevent disease transmission
3. Fleas and Ticks and Mosquitoes! Oh My!
4. Mega-Catch™ 3000 Combination Lure Attracts Asian Tiger Mosquitoes (Aedes Albopictus)
5. Private Sector, President's Malaria Initiative Join Forces to Strengthen Angolas Capacity to Control Mosquitoes
6. Microbiotic technology developed for microinjection of zebrafish embryos
7. Lab-on-chip testing for bird flu developed by Singapore scientists
8. Mobility-enhancing device developed at University of Alberta will receive prestigious da Vinci Award
9. New Denver Area Program Developed For Teens in Crisis
10. Genomic technologies to identify toxic chemicals should be developed
11. New system for classifying infant lung disease developed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... United ... Nesbitt as the latest addition to its growing list of Partner Firms. ... the Southeast, from Orlando to Huntsville and in between. , Harnessing the experience ...
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric therapists are challenged ... Research shows that the Goal Attainment Scale (GAS) captures 20% more change in ... learn more about the Goal Attainment Scale, Education Resources Inc. is offering a ...
(Date:2/10/2016)... ... February 10, 2016 , ... IDEX Health & Science, ... stainless steel (PLS) columns combine the strength of traditional stainless steel with the ... biological samples while operating at ultra-high pressures of 20,000 psi. The higher operating ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Anxiety of older ... the start of Medicare Part D a decade ago, according to The Senior ... older adults on how they are coping with rapidly rising costs. “The implications ...
(Date:2/10/2016)... ... February 09, 2016 , ... ... the cause of injury may be one of many possible sources: sports, car ... Continuing Education Course , Mastering Rehab Solutions for the Complexities of Concussions ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Feb. 10, 2016  Silicon Biosystems Menarini Inc., ... that help uncover the biological complexities of disease ... a developer of innovative technologies for genomics research, ... aimed at enabling translational researchers to obtain high-quality ... hundred tumor and normal cells in an optimized ...
(Date:2/10/2016)... India , February 10, 2016 ... a new market research report "Pharmaceutical Packaging Equipment Market ... Wrapping, Labeling & Serialization), by Product Type (Tablet, Powder, ... 2020", published by MarketsandMarkets, studies the global market during the ... expected to grow at a CAGR of 6.9% during ...
(Date:2/10/2016)... Feb. 9, 2016 On Tuesday, ... (FDA) met with its Arthritis Advisory Committee ... of Johnson & Johnson,s Remicade and most ... in the U.S. The Biologics Prescribers Collaborative ... - Alliance for Patient Access, American Association ...
Breaking Medicine Technology: